Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Healthcare resource utilization in patients with metastatic melanoma receiving first-line therapy with dabrafenib + trametinib versus nivolumab or pembrolizumab monotherapy
PaperCitations, authors & open-access status
Healthcare resource utilization in patients with metastatic melanoma receiving first-line therapy with dabrafenib + trametinib versus nivolumab or pembrolizumab monotherapy is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 8 citations, 2018 year and bronze oa status.
8
Citations
2018
Year
bronze
OA Status